Harvard Bioscience Revenue, Profits - HBIO Quarterly Income Statement

Add to My Stocks
$2.7 $0.07 (2.7%) HBIO stock closing price Aug 23, 2017 (Closing)

Financial statements provide us with a way to gain insights and undertake the fundamental analysis of a company. Checking Harvard Bioscience stock price alone is not sufficient. In the income statement, an investor can look at important parameters like revenue, gross profits, net profits, and EPS basic to gain deeper insights. The income statement for HBIO which implies a QoQ revenue growth of $1.05M is specific to a period of time. Investors typically check YoY or QoQ revenue growth. Along with Harvard Bioscience assets and Harvard Bioscience free cash flow, profits as shown in profit and loss statement give key insights about the business. The profits have increased from $-1.07M QoQ and 2017-Q2 revenue is $25.21M. View details of revenue and profits for Harvard Bioscience for latest & last 40 quarters.

show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec.2017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Harvard Bioscience Net Sales or Revenues
Cost Of Goods Sold (COGS)13.93M12.65M14.32M13.31M14.46M14.01M15.46M14M16.2M14.28M
Harvard Bioscience Gross Profit
Research & Development Expense1.3M1.28M1.17M1.3M1.5M1.42M1.55M1.42M1.71M1.74M
Selling General & Admin Expense9.39M10.25M11.45M10.46M10.32M11.06M10.61M10.4M10.1M10.08M
Income Before Depreciation Depletion Amortization0.6M-0.03M-0.49M-0.08M-0.15M0.45M0.78M-0.1M0.77M-0.35M
Depreciation Depletion Amortization0.6M0.59M0.63M0.72M0.69M0.68M0.69M0.66M0.67M0.79M
Non Operating Income-0.28M-0.24M0.29M0.07M0.25M-0.05M-0.23M-0.11M-0.31M-0.39M
Interest Expense0.18M0.16M0.16M0.14M0.18M0.16M0.22M0.2M0.21M0.22M
Harvard Bioscience Pretax Income
Provision for Income Taxes-0.08M0.02M0.33M0.75M-0.05M0.19M16.8M-0.24M-0.77M-0.36M
Minority Interest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-0.38M-1.07M-1.32M-1.64M-0.71M-0.64M-17.14M-0.85M0.35M-1.4M
Extraordinary Items & Discontinued Operations----------
Harvard Bioscience Net Income (Profit/Loss)
Average Shares used to compute Diluted EPS34.7M34.58M34.38M34.33M34.13M34.01M33.95M33.93M35.03M32.91M
Average Shares used to compute Basic EPS34.7M34.58M34.38M34.33M34.13M34.01M33.95M33.93M33.57M32.91M
Income Before Nonrecurring Items0.27M-0.15M0.46M0.49M0.99M0.93M0.46M0.4M1.13M0.38M
Income from Nonrecurring Items-0.66M-0.92M-1.78M-2.13M-1.7M-1.57M-17.6M-1.24M-0.78M-1.78M
Harvard Bioscience Earnings Per Share Basic Net
Harvard Bioscience Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items0.01-
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common----------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Income statement for another ticker

It is very helpful to read a report on Harvard Bioscience stock analysis. An investor must check the following items in an income statement:
  • Topline: A growing topline, as seen from the Harvard Bioscience revenue chart, as is the case with Harvard Bioscience indicates a growing business. One needs to compare the QoQ or YoY topline growth of HBIO stock with its peers like NEWP stock and MTSC stock to see if the growth compares well with what can be expected for a company in that industry.
  • Bottom line: The Bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $25.21M - other expenses = $-0.38M for HBIO stock. An improving bottomline implies that the company is growing profits.
The income statement is also called the profit and loss statement. Apart from the income statement, one can check the Harvard Bioscience historical stock prices to check how the price has moved with time. .

Harvard Bioscience Income Statement - Key Financial Ratios

PS ratio (
price sales ratio
Net profit margin
Dividend yield